MedAdvisor Requests Trading Halt for Capital Raising and Strategic Review
Key points
- MedAdvisor requests trading halt pending announcement on capital raising and strategic review
- Trading halt to remain in place until announcement or start of trading on April 2
- Company not aware of any reason why trading halt should not be granted
Full summary
MedAdvisor Ltd, an ASX-listed company, has requested a trading halt in its securities effective from the commencement of trading on Monday, 31 March 2025. The trading halt has been requested pending the release of an announcement by the company in relation to a capital raising by way of a placement and an update on the strategic review. The trading halt is expected to remain in place until the earlier of the announcement being made or the commencement of trading on Wednesday, 2 April 2025. The company has advised that it is not aware of any reason why the trading halt should not be granted, or of any information necessary to inform the market or ASX about the trading halt.
Sign in for more about this company, including guidance changes and other insights.
Sign in